PL369525A1 - Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors - Google Patents
Aminoindane derivatives as serotonin and norepinephrine uptake inhibitorsInfo
- Publication number
- PL369525A1 PL369525A1 PL02369525A PL36952502A PL369525A1 PL 369525 A1 PL369525 A1 PL 369525A1 PL 02369525 A PL02369525 A PL 02369525A PL 36952502 A PL36952502 A PL 36952502A PL 369525 A1 PL369525 A1 PL 369525A1
- Authority
- PL
- Poland
- Prior art keywords
- serotonin
- uptake inhibitors
- norepinephrine uptake
- aminoindane derivatives
- aminoindane
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 2
- XJEVHMGJSYVQBQ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-1-amine Chemical class C1=CC=C2C(N)CCC2=C1 XJEVHMGJSYVQBQ-UHFFFAOYSA-N 0.000 title 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 title 1
- 229940076279 serotonin Drugs 0.000 title 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101939 | 2001-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL369525A1 true PL369525A1 (en) | 2005-05-02 |
Family
ID=33547528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02369525A PL369525A1 (en) | 2001-12-21 | 2002-12-18 | Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
Country Status (8)
| Country | Link |
|---|---|
| KR (1) | KR20040075904A (is) |
| AR (1) | AR037936A1 (is) |
| BR (1) | BR0214987A (is) |
| EA (1) | EA007655B1 (is) |
| IS (1) | IS7282A (is) |
| PL (1) | PL369525A1 (is) |
| UA (1) | UA76266C2 (is) |
| ZA (1) | ZA200403970B (is) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8628644D0 (en) * | 1986-12-01 | 1987-01-07 | Lunbeck A S H | Intermediates |
| DK286990D0 (da) * | 1990-12-04 | 1990-12-04 | Lundbeck & Co As H | Indanderivater |
| DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
| GB9315600D0 (en) * | 1993-07-28 | 1993-09-08 | Smithkline Beecham Plc | Compounds |
| GB9315566D0 (en) * | 1993-07-28 | 1993-09-08 | Smithkline Beecham Plc | Medicaments |
| EP0738149B1 (en) * | 1994-01-10 | 2006-11-29 | Teva Pharmaceutical Industries, Ltd. | 1-aminoindan derivatives and compositions thereof |
| WO1998055447A1 (en) * | 1997-06-05 | 1998-12-10 | Venantius Limited | 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them |
| EP1044184A1 (en) * | 1998-01-09 | 2000-10-18 | Pharm-Eco Laboratoires, Incorporated | Synthesis of 3-aryl-1-indanamines |
-
2002
- 2002-05-21 IS IS7282A patent/IS7282A/is unknown
- 2002-12-18 EA EA200400846A patent/EA007655B1/ru not_active IP Right Cessation
- 2002-12-18 PL PL02369525A patent/PL369525A1/xx not_active Application Discontinuation
- 2002-12-18 UA UA20040705315A patent/UA76266C2/uk unknown
- 2002-12-18 BR BR0214987-7A patent/BR0214987A/pt not_active IP Right Cessation
- 2002-12-18 KR KR10-2004-7009905A patent/KR20040075904A/ko not_active Withdrawn
- 2002-12-19 AR ARP020105023A patent/AR037936A1/es not_active Application Discontinuation
-
2004
- 2004-05-21 ZA ZA200403970A patent/ZA200403970B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS7282A (is) | 2004-05-21 |
| KR20040075904A (ko) | 2004-08-30 |
| EA200400846A1 (ru) | 2004-12-30 |
| UA76266C2 (en) | 2006-07-17 |
| ZA200403970B (en) | 2005-08-22 |
| EA007655B1 (ru) | 2006-12-29 |
| AR037936A1 (es) | 2004-12-22 |
| BR0214987A (pt) | 2004-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1400012I1 (hu) | Szerotonin újrafelvételt gátló fenilpiperazin-származékok | |
| PL364580A1 (en) | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | |
| TWI319387B (en) | Benzamide derivatives | |
| AU2003296954A8 (en) | Analgesic combination comprising nalbuphine | |
| AU2002306491A1 (en) | Serotonin reuptake inhibitor formulations | |
| NO20016406D0 (no) | Höyselektive norepinefrin-reopptaksinhibitorer | |
| IS2529B (is) | Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar | |
| PL364821A1 (en) | Phenylpiperazines as serotonin reuptake inhibitors | |
| IS8136A (is) | N-pýrrólidín-3-ýl-amíð afleiður sem serótónín og noradrenalín endurupptöku hindrar | |
| EG24345A (en) | Reconstitutable parenteral composition | |
| IL154343A0 (en) | Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors | |
| IL162308A0 (en) | Aminoindane derivatives as serotonin and norepinephrine uptakeinhibitors | |
| PT1501804E (pt) | Derivados de isoquinolina | |
| IL172965A0 (en) | The combination of a serotonin reuptake inhibitors and agomelatine | |
| AU2003290735A8 (en) | Inhibitors of monoamine uptake | |
| GB2389851B (en) | Inhibitor of monoamine uptake | |
| HUP0303185A3 (en) | Glyt-1 inhibitors | |
| IL173968A0 (en) | The combination of a serotonin reuptake inhibitor and loxapine | |
| IS7282A (is) | Amínóindan afleiður sem serótónín og noradrenalínupptökuhindrar | |
| AU2003290363A8 (en) | Therapeutic use of selective noradrenaline reuptake inhibitors | |
| SI1545552T1 (sl) | Kombinacijska terapija, pri kateri je uporabljen inhibitor ponovnega privzema serotonina | |
| HU0800579D0 (en) | Highly selective norepinephrine reuptake inhibitors and methods using the same | |
| HK1060563A (en) | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | |
| GB0228610D0 (en) | Benzamide derivatives | |
| GB0229930D0 (en) | Benzamide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |